510(k) Report

510(k) · Cleared

Cleared

Chase Aortic Perfusion Cannula

K970914510(k) TraditionalCleared May 13, 199762-day reviewClass II21 CFR 870.4210

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Chase Medical, Inc. · DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

Cleared on May 13, 1997 as substantially equivalent to K770429 (3M Health Care, Sarns, 1977) and 1 other predicate after a 62-day review. Its family tree reaches back 1 generation to 1977.

Decided
May 13, 1997
Review
62 days
Class
Class II
Product code
DWF
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K770429 (1977). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1979: 1 other ancestorK770429 · Cannulae, Aortic, Arch, High Flow · 3M Health Care, Sarns · 1977 · recalled19751980198519901995
Other ancestors, by generation 1 generation back: 1 other ancestor K770429 · Cannulae, Aortic, Arch, High Flow · 3M Health Care, Sarns · 1977 · recalled0
  1. Root · 1 generation backK770429 Cannulae, Aortic, Arch, High Flow3M Health Care, Sarns · 1977 · Recalled
  2. This deviceK970914 Chase Aortic Perfusion CannulaChase Medical, Inc. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K770429Cannulae, Aortic, Arch, High Flow3M Health Care, Sarns197712
0 (this device)K970914Chase Aortic Perfusion CannulaChase Medical, Inc.1997—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
197910
FIG. 1 — Lineage of K970914, 1977–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DWF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DWF device

  1. #1 K251258 MC2™ Two-Stage Venous Cannula; MC2X™…score 14.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K770429Cannulae, Aortic, Arch, High Flow
Summary page 1
…ssification: Class Il device Safety and Effectiveness: Substantial Equivalence: This device is substantially equivalent to the combination of Sarns Aortic Arch Cannula (K770429), DLP Aortic Root Cannula (K790565), and an aortic cross clamp. Other Safety and Effectiveness Data: Materials: All materials a…
3M Health Care, Sarns197712
*K790565Aortic Root Cannula
Summary page 1
…y and Effectiveness: Substantial Equivalence: This device is substantially equivalent to the combination of Sarns Aortic Arch Cannula (K770429), DLP Aortic Root Cannula (K790565), and an aortic cross clamp. Other Safety and Effectiveness Data: Materials: All materials are identical to materials used in s…
Dlp, Inc.19791
*—aortic cross clamp
Named without a submission number
—

Also cleared against K770429: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 2 of the 2 ancestors have a recall of any class.
  • 4 other devices also cite its predicate K770429.

How does its category compare?

All DWF devices

DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DWF

4in 2025

2007: 22008: 62009: 82010: 32011: 52012: 102013: 92014: 142015: 92016: 32017: 52018: 52019: 32020: 32021: 52022: 22023: 22024: 32025: 42026 (partial year): 8
2007high 14 (2014) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DWF

89in 2025

2008: 95 days median2009: 148 days median2010: 62 days median2011: 85 days median2012: 110 days median2013: 110 days median2014: 110 days median2015: 46 days median2016: 32 days median2017: 127 days median2018: 30 days median2019: 120 days median2020: 30 days median2021: 358 days median2024: 29 days median2025: 89 days median2026 (partial year): 81 days median
2007high 358 (2021) · low 29 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DWF

4in 2024

2007: 252008: 252009: 212010: 262011: 132012: 372013: 14, 1 Class I2014: 62015: 3, 1 Class I2016: 32017: 2, 1 Class I2018: 102019: 22021: 32024: 42026 (partial year): 20
2007high 37 (2012) · low 0 (2020)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · DWF

1,020in 2025

2007: 1212008: 1262009: 992010: 1972011: 2122012: 2332013: 2382014: 3252015: 2182016: 1442017: 1012018: 1182019: 1792020: 1422021: 1622022: 2762023: 4702024: 4012025: 1,020
2007high 1,020 (2025) · low 99 (2009)2025

MAUDE reports naming product code DWF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—25121
200869525126
200981482199
201036226197
201158513212
20121011037233
2013911014 (1)238
2014141106325
20159463 (1)218
20163323144
201751272 (1)101
201853010118
201931202179
20203300142
202153583162
20222—0276
20232—0470
20243294401
202548901,020
202688120—

What is it indicated for?

The Aortic Perfusion Cannula is indicated for use for perfusion of the ascending aorta during surgical procedures requiring cardiopulmonary bypass. Additionally, the Aortic Perfusion Cannula can be used to occlude the ascending aorta as well as deliver cardioplegia solution to and aspirate air from the aorta.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K970914: Chase Aortic Perfusion Cannula.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K970914

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026